Honoree: Eric Reiman, M.D., Executive Director, Banner Alzheimer’s Institute
Dr. Eric Reiman’s goal as a researcher is to find a cure for Alzheimer’s disease before another generation is lost. In order to achieve this goal, Reiman conducts research utilizing brain imaging, genomics, early detection and tracking of Alzheimer’s disease, disease-slowing therapies and prevention therapies.
He serves as executive director of Banner Alzheimer’s Institute, clinical director of the Neurogenomics Division at the Translational Genomics Research Institute, professor and associate head of psychiatry at the University of Arizona and director of the Arizona Alzheimer’s Consortium.
In using brain-imaging technology, Reiman and his team are characterizing regions of the brain that are used for different aspects of emotion, memory, pain, hunger and satiation, and those that work together to create anxiety disorders. For years, Reiman and his team also have used brain-imaging techniques to detect and record brain changes in cognitively normal carriers and non-carriers of a common Alzheimer’s susceptibility gene. In 2007, Reiman and his colleagues published the first genome-wide association studies of Alzheimer’s disease and normal human memory.
Finalist: David Adelson, M.D., FACS, FAAP, Medical Director, Children’s Neuroscience, Phoenix Children’s Hospital
Dr. David Adelson has devoted much of his career to researching avenues that might improve the lives of people around the world, especially children. He founded the Children’s Neuroscience Institute at Phoenix Children’s Hospital (PCH) and currently serves as its director. He also holds the position of division chief of neurosurgery at PCH. In the time he has off from his practice, Adelson is currently involved with eight separate research projects.
Included in those research projects is a multi-centered clinical trial with the Cool Kids Trial that is studying whether moderate hypothermia treatment can improve the outcomes of children who have experienced traumatic brain injury.